- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Estrogen Receptor
Total 19621 results
-
Veru Inc.TerminatedMetastatic Breast CancerUnited States, Spain, Poland, Ukraine
-
Accutar Biotechnology IncTerminated
-
Bristol-Myers SquibbCompleted
-
OHSU Knight Cancer InstituteGenentech, Inc.; Oregon Health and Science UniversityWithdrawnAnatomic Stage III Breast Cancer AJCC v8 | Recurrent Ovarian Carcinoma | Anatomic Stage IV Breast Cancer AJCC v8 | Advanced Malignant Solid Neoplasm | Advanced Pancreatic Carcinoma | Stage II Pancreatic Cancer AJCC v8 | Stage III Pancreatic Cancer AJCC v8 | Stage IV Pancreatic Cancer AJCC v8 | Recurrent... and other conditionsUnited States
-
Novartis PharmaceuticalsCompleted
-
Memorial Sloan Kettering Cancer CenterEli Lilly and CompanyActive, not recruitingAdenocarcinoma of EndometriumUnited States
-
Arvinas Estrogen Receptor, Inc.PfizerActive, not recruitingBreast CancerUnited States, Spain
-
Mayo ClinicNational Cancer Institute (NCI)Active, not recruitingStage IV Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Invasive Breast Carcinoma | Stage IIIC Breast Cancer | HER2/Neu Negative | Stage III Breast Cancer | Postmenopausal | Estrogen Receptor StatusUnited States
-
M.D. Anderson Cancer CenterBayerActive, not recruitingOvarian Cancer | Endometrial CancerUnited States
-
University Health Network, TorontoActive, not recruitingBreast Cancer | Advanced Solid CancersCanada
-
Shayna Showalter, MDActive, not recruitingBreast Cancer FemaleUnited States
-
PfizerArvinas Estrogen Receptor, Inc.CompletedHealthy ParticipantsBelgium
-
Dana-Farber Cancer InstitutePfizerActive, not recruiting
-
St. Louis UniversityTerminatedTransgenderism | Gender IncongruenceUnited States
-
Beth Israel Deaconess Medical CenterDana-Farber Cancer InstituteTerminatedBreast Cancer | Human Epidermal Growth Factor 2 Negative Carcinoma of Breast | Estrogen Receptor Positive Breast Cancer | Node-negative Breast CancerUnited States
-
GOG FoundationNovartis PharmaceuticalsActive, not recruitingAdvanced, Persistent, or Recurrent Endometrial CancerUnited States
-
ETOP IBCSG Partners FoundationNational Cancer Institute (NCI); Breast International GroupActive, not recruitingBreast CancerUnited States, Australia, Switzerland, Italy, Canada, Belgium, Peru, United Kingdom, Egypt, New Zealand, Slovenia, South Africa, Sweden, Hungary, India, Germany, Brazil
-
ETOP IBCSG Partners FoundationNational Cancer Institute (NCI); NCIC Clinical Trials Group; Cancer and Leukemia... and other collaboratorsActive, not recruitingRecurrent Breast Carcinoma | Stage IIIA Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Estrogen Receptor Positive Breast Cancer | Progesterone Receptor Positive TumorUnited States, Canada, Switzerland
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Active, not recruitingHR-positive, HER2-negative Breast NeoplasmsChina
-
University of Alabama at BirminghamNovartis Pharmaceuticals; Tracon Pharmaceuticals Inc.Completed
-
University of Alabama at BirminghamGlaxoSmithKline; AbbVie; Breast Cancer Research Foundation of AlabamaActive, not recruitingMetastatic Triple Negative Breast CancerUnited States
-
Fundacion CRIS de Investigación para Vencer el...Bayer; Pfizer; Apices Soluciones S.L.CompletedHormone Receptor Positive Malignant Neoplasm of Breast | Breast Cancer MetastaticSpain
-
PfizerActive, not recruitingHR+ HER2- Metastatic Breast Cancer, Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer, Triple Negative Breast Cancer, Male Breast CancerUnited States, Japan, Canada, Russian Federation, Bulgaria, Ukraine
-
Eisai Inc.CompletedBreast Cancer | Breast Neoplasms | Cancer, Breast | Breast Cancer Female | Estrogen Receptor Positive Tumor | Breast Adenocarcinoma | ER Positive | Estrogen-receptor Positive Breast CancerFrance, United Kingdom, United States
-
Dompé Farmaceutici S.p.ACompletedSARS CoV 2 InfectionFrance, Spain, Italy
-
Eisai Co., Ltd.Active, not recruiting
-
Royal Marsden NHS Foundation TrustPfizer; Breast Cancer NowActive, not recruitingGastric Cancer | Triple Negative Breast Cancer | Lobular Breast Carcinoma | CDH1 Gene MutationUnited Kingdom
-
Carrick Therapeutics LimitedCompletedAdvanced Solid MalignanciesUnited States, United Kingdom
-
Institut CurieRain Oncology IncTerminatedAdvanced or Metastatic Breast CancerFrance
-
Georgetown UniversityPfizerActive, not recruitingMetastatic Breast Cancer | Human Epidermal Growth Factor 2 Negative Carcinoma of Breast | Hormone Receptor Positive Breast CancerUnited States
-
Washington University School of MedicinePfizerActive, not recruitingBreast NeoplasmsUnited States
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI)Active, not recruitingBreast CancerUnited States, Puerto Rico
-
University of NebraskaNational Cancer Institute (NCI)Active, not recruitingStage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Invasive Breast Carcinoma | Stage IA Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor Negative | Estrogen Receptor Positive | HER2/Neu Negative | HER2/Neu Positive | Progesterone... and other conditionsUnited States
-
Canadian Cancer Trials GroupPfizerCompleted
-
Merck Sharp & Dohme LLCActive, not recruitingBreast CancerJapan, Poland, United States, Australia, Belgium, Brazil, Canada, China, Colombia, Costa Rica, France, Germany, Hungary, Ireland, Israel, Korea, Republic of, New Zealand, Portugal, Puerto Rico, Russian Federation, Spain, Taiwan, Ukr... and more
-
M.D. Anderson Cancer CenterBristol-Myers Squibb; Susan G. Komen Breast Cancer FoundationActive, not recruiting
-
Vanderbilt-Ingram Cancer CenterActive, not recruitingEstrogen Receptor-positive Breast CancerUnited States
-
Mayo ClinicNational Cancer Institute (NCI)Active, not recruitingRecurrent Breast Carcinoma | Stage IV Breast Cancer AJCC v6 and v7 | Stage III Breast Cancer AJCC v7 | Stage IIIA Breast Cancer AJCC v7 | Stage IIIB Breast Cancer AJCC v7 | Stage IIIC Breast Cancer AJCC v7 | Advanced Breast Carcinoma | Metastatic Breast Carcinoma | Locally Advanced Breast CarcinomaUnited States
-
Andrei IagaruGeneral ElectricCompletedBreast Carcinoma | Estrogen Receptor PositiveUnited States
-
Novartis PharmaceuticalsTerminated
-
University of PennsylvaniaActive, not recruitingBone Metastases | Estrogen Receptor Positive Breast CancerUnited States
-
University of Alabama at BirminghamM.D. Anderson Cancer Center; National Cancer Institute (NCI); University of Colorado... and other collaboratorsActive, not recruitingBreast CancerUnited States, Canada
-
Rachel MejiaUniversity of Wisconsin, Madison; Society for Reproductive Investigation; American...Active, not recruitingPolycystic Ovary Syndrome | Infertility | PCOSUnited States
-
Jazz PharmaceuticalsActive, not recruitingHER2+/HR+ Breast CancerUnited States, Spain, Canada
-
Novartis PharmaceuticalsActive, not recruiting
-
AstraZenecaCompletedAdvanced and Metastatic Breast CancerUnited States, United Kingdom
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI)Active, not recruitingStage IV Breast Cancer | Recurrent Breast Cancer | Estrogen Receptor-positive Breast Cancer | Progesterone Receptor-positive Breast Cancer | HER2-negative Breast Cancer | Invasive Ductal Breast CarcinomaUnited States
-
University of AarhusGCP-unit at Aarhus University Hospital, Aarhus, Denmark; REDCapCompleted
-
PfizerCompletedBreast NeoplasmsUnited States, Canada, Spain, United Kingdom, Australia, Belgium, Korea, Republic of, Japan, Czechia, France, Germany, Hungary, Ireland, Italy, Poland, Russian Federation, Taiwan, Ukraine